Raltegravir Potassium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 9 USDMF, 1 CEP/COS, 5 EU WC, 4 KDMF, 8 NDC API, 21 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

17 Intermediates Suppliers

17 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

29 FDF Dossiers, 7 FDA Orange Book, 13 Europe, 3 Canada, 2 Australia, 3 South Africa, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 400MG BASE, TABLET;ORAL - EQ 600MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 7 Rochem International Inc, 17 SPI Pharma, 5 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 6 Faran Shimi Pharmaceutical, 1 Chynops Pharma, 12 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 1 Bioplus Life Sciences, 1 Clariant, 10 Corel Pharma Chem, 5 DFE Pharma, 8 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 33 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 27 Roquette, 6 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 3 The Dow Chemical Company, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

72 Fillers, Diluents & Binders, 56 Coating Systems & Additives, 33 Direct Compression, 26 Controlled & Modified Release, 25 Thickeners and Stabilizers, 25 Taste Masking, 20 Lubricants & Glidants, 20 Disintegrants & Superdisintegrants, 19 Chewable & Orodispersible Aids, 18 Film Formers & Plasticizers, 17 Granulation, 15 Co-Processed Excipients, 14 Parenteral, 11 Solubilizers, 8 Topical, 7 Rheology Modifiers, 5 Empty Capsules, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 3 Emulsifying Agents, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 10 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 9 Finished Drug Prices, 10 Annual Reports

MARKET PLACE

2 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

25 US Patents, 9 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 Others

2 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22145 / DOSAGE - TABLET;ORAL - EQ 600MG BASE

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
RALTEGRAVIR POTASSIUM(UNII: 43Y000U234) (RALTEGRAVIR - UNII:22VKV8053U)	RALTEGRAVIR	400mg

Inactive Ingredients

Ingredient Name	REMEDYREPACK INC.	A-S Medication Solutions	Avera McKennan Hospital
ANHYDROUS DIBASIC CALCIUM PHOSPHATE(L11K75P92J)
BUTYLATED HYDROXYTOLUENE(1P9D0Z171K)
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS(L11K75P92J)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
FERRIC OXIDE RED(1K09F3G675)
FERROSOFERRIC OXIDE(XM0M87F357)
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
HYPROMELLOSES(3NXW29V3WO)
LACTOSE MONOHYDRATE(EWQ57Q8I5X)
MAGNESIUM STEARATE(70097M6I30)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
POLOXAMER 407(TUF2IVW3M2)
POLYETHYLENE GLYCOL 3350(G2M7P15E5P)
POLYVINYL ALCOHOL(532B59J990)
POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990)
SODIUM STEARYL FUMARATE(7CV7WJK4UI)
TALC(7SEV7J4R1U)
TITANIUM DIOXIDE(15FIX9V2JP)

Drug Product Composition: Raltegravir Potassium